Article
High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes.
Cell cycle (Georgetown, Tex.) - 1 Nov 2022
Yu Zhenghong, Liu Zhendong, Lian Xiaoyu, Cheng Xingbo, Liu Binfeng, Zhang Bo, Wang Hongbo, Wang Jialin, Li Ang, Ren Zhishuai, Pang Bo, Qian Rongjun, Gao Yanzheng
Abstract excerpt
HOXA4 is a novel oncogene that has been observed in many kinds of tumors, but its role during glioma carcinogenesis and its clinical significance in diagnosing and prognosis human glioma remains unknown. In the present study, the Chinese Glioma Atlas (CGGA)-RNA sequencing database, CGGA microarray, and The Cancer Genome Atlas (TCGA)-RNA seq data from 1674 glioma patients were obtained from online databases and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
